Activating a protein to understand pancreatic beta cell dysfunction in diabetes
Forced Activation of ATF6 Drives Pancreatic Beta Cell Dysfunction
This study is looking at how turning on a certain protein in the pancreas might help improve the way insulin-producing cells work, which could be really helpful for people with Type 2 Diabetes.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11082195 on NIH RePORTER |
What this research studies
This research investigates how activating a specific protein, ATF6α, affects the function of pancreatic beta cells, which are crucial for insulin production and blood sugar regulation. The study uses genetically modified mice to observe the effects of this activation on glucose tolerance and insulin secretion. By exposing these mice to a pharmacological agent, researchers can control the timing and location of ATF6α activation, allowing for a detailed analysis of its role in diabetes. The findings aim to uncover mechanisms that contribute to beta cell dysfunction in Type 2 Diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Type 2 Diabetes or those at risk of developing the condition.
Not a fit: Patients with Type 1 Diabetes or those without any form of diabetes may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for improving insulin production and glucose regulation in patients with Type 2 Diabetes.
How similar studies have performed: Previous research has shown that targeting the Unfolded Protein Response can have beneficial effects in other models of diabetes, suggesting potential for success in this approach.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Rappa, Andrew — Weill Medical Coll of Cornell Univ
- Study coordinator: Rappa, Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.